Loading...
•
Feb 01
Bath & Body Works Q4 2024 Earnings Report
Reported lower net sales and earnings per share, but exceeded guidance expectations.
Key Takeaways
Bath & Body Works reported Q4 2024 net sales of $2.788 billion, a 4.3% decline due to an extra week in the prior year. EPS was $2.09, down from $2.55 last year. Operating income fell to $678 million, while net income dropped to $453 million. Despite these declines, results exceeded company guidance.
Net sales declined by 4.3% year-over-year, impacted by an extra week in 2023.
EPS was $2.09, surpassing company guidance.
Operating income decreased to $678 million from $696 million last year.
Board authorized a new $500M share repurchase program.
Bath & Body Works
Bath & Body Works
Bath & Body Works Revenue by Segment
Bath & Body Works Revenue by Geographic Location
Revenue by Segment
Stores – U.S. and Canada Revenue
CapyFin.comDirect – U.S. and Canada Revenue
CapyFin.comInternational Revenue
CapyFin.comRevenue by Geographic Location
U.S. and Canada Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Bath & Body Works expects 1-3% net sales growth in 2025, with EPS between $3.25 and $3.60.
Positive Outlook
- Company forecasts 1-3% sales growth for fiscal 2025.
- EPS guidance for full-year 2025 between $3.25 and $3.60.
- Expected free cash flow of $750M to $850M in fiscal 2025.
- Board authorized a new $500M share repurchase program.
- Continued investments in product innovation and digital channels.
Challenges Ahead
- Decline in Q4 2024 net sales due to an extra week in prior year.
- Higher operating expenses could pressure margins in 2025.
- Potential negative impact from recently enacted tariffs on imports.
- Continued uncertainty in the broader retail sector.
- International segment saw a 10.1% decline in revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income